SecBot SecBot

BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.
OTC· Laboratory Analytical Instruments· CIK 0001310488 Industrials & Manufacturing
$7.40 −0.60 (−7.50%)
Oct 27 4:00 PM ET · prev $8.00
Next earnings
Nov 17
in 20 days
1 year
+825.0%
from $0.8000 · Oct 28
30 days
−15.6%
from $8.77
52-week range
$0.1800–10.01
−26% from high · low Feb 17
Avg volume 20D
9.7K
Oct 21 spike 49.8K
Short interest
2.7K
+17.4%
Days to cover
1.0
at average volume
Insider net
−$400.5K
0 buyers · 1 seller · 12 mo
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 4 reports · 90 days
Balance 1 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/4 ·Next Earnings date, Nov 17, 2026
Strongest BEARISH BioForce Nanosciences issued 4,516,909 restricted shares of common stock in a private placement to pay for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $400.5K.

  • Short sellersBUILDING

    Short interest +17.4% to 2.7K shares. 1.0 days to cover.

  • TrendRANGE

    4% above its 50-day average.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
BFNH Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Aug 10, 2026
Earnings date
BFNH Q2 2026 Earnings Scheduled — 2026-08-10
May 11, 2026
Earnings date
BFNH Q1 2026 Earnings Scheduled — 2026-05-11
Apr 15, 2026
Earnings date
BFNH Q4 2025 Earnings Scheduled — 2026-04-15
Apr 6, 2026
Earnings date
BFNH Q4 2025 Earnings Scheduled — 2026-04-06

Insider ledger

Form 4
$0
bought · 0 insiders
$400.5K
sold · 1 insider
DateInsiderTypeValue
Aug 31, 2026
KAISER RICHARD KAISER
CEO & CFO
AWARD$174.3K
Aug 20, 2026
KAISER RICHARD KAISER
CEO & CFO
OTHER$25.0K
Apr 22, 2026
Ferguson Merle
Director
SELL$400.5K
Apr 20, 2026
KAISER RICHARD KAISER
CEO & CFO
GIFT$4.1K
Apr 20, 2026
Ferguson Merle
Director
GIFT$4.1K
Apr 20, 2026
Ferguson Merle
Director
GIFT$144.1K

Earnings setup

Estimates
Nov 17
reports in 20 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
2,723
shares short
+17.4%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 7, 2026 SEC
Bioforce Nanosciences Holdings, Inc. (BFNH) disclosed the assignment of an oil and gas lease covering approximately…
8-K — Impact 2/10
Sep 4, 2026 SEC
BioForce Nanosciences issued 4,516,909 restricted shares of common stock in a private placement to pay for services…
8-K — Impact 6/10
Aug 31, 2026 Insider
KAISER RICHARD KAISER was granted 316,909 shares
CEO & CFO @ $0.5500 ($174.3K)
Aug 20, 2026 Insider
KAISER RICHARD KAISER disposed of 38,462 shares
CEO & CFO @ $0.6500 ($25.0K)
Aug 18, 2026 SEC
Bioforce Nanosciences received a Prospective Resources Report from Ryder Scott for its Nevada oil and gas lease claims…
8-K — Impact 3/10
Aug 10, 2026 Earnings calendar
BFNH Q2 2026 Earnings Scheduled — 2026-08-10
Apr 22, 2026 Insider
Ferguson Merle sold 26,700,000 shares
Director @ $0.0150 ($400.5K)

SecBot reports

7 filings · 0 bullish · 1 bearish · 1 mixed · 5 neutral
All BFNH filing & press-release reports (7)